KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Interest Expenses (2016 - 2025)

Astrana Health's Interest Expenses history spans 16 years, with the latest figure at $17.7 million for Q3 2025.

  • For Q3 2025, Interest Expenses rose 100.07% year-over-year to $17.7 million; the TTM value through Sep 2025 reached $40.5 million, up 32.93%, while the annual FY2024 figure was $33.1 million, 105.55% up from the prior year.
  • Interest Expenses for Q3 2025 was $17.7 million at Astrana Health, up from $7.4 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $17.7 million in Q3 2025 and bottomed at $967000.0 in Q3 2021.
  • The 5-year median for Interest Expenses is $3.6 million (2023), against an average of $5.0 million.
  • The largest annual shift saw Interest Expenses tumbled 60.79% in 2021 before it soared 204.66% in 2023.
  • A 5-year view of Interest Expenses shows it stood at $1.1 million in 2021, then skyrocketed by 144.72% to $2.6 million in 2022, then skyrocketed by 110.81% to $5.4 million in 2023, then soared by 48.82% to $8.1 million in 2024, then surged by 119.58% to $17.7 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Interest Expenses are $17.7 million (Q3 2025), $7.4 million (Q2 2025), and $7.3 million (Q1 2025).